The Underlying Causes: Why Getting to the Root Matters
At a Glance
Finding the exact root cause of bronchiectasis is crucial because it directly influences your treatment options. Doctors use specialized blood, genetic, and breathing tests to identify underlying issues like immune deficiencies, Primary Ciliary Dyskinesia, or past infections to provide precise care.
A diagnosis of bronchiectasis is often just the beginning of the journey. While the CT scan shows what is happening—your airways have widened and scarred—it doesn’t explain why. Finding the root cause of your bronchiectasis is one of the most important steps in your care because the “why” often dictates the “how” of your treatment [1][2].
CF vs. Non-CF Bronchiectasis
The first big distinction doctors make is between Cystic Fibrosis (CF) and non-CF bronchiectasis.
- Cystic Fibrosis: This is a specific genetic condition caused by mutations in the CFTR gene [3]. It affects how salt and water move in and out of cells, creating exceptionally thick, sticky mucus throughout the body.
- Non-CF Bronchiectasis: This is an “umbrella term” for airway damage caused by a wide variety of other factors [4].
It is important to know that treatments that work for CF (like certain inhaled medications) may not work for non-CF bronchiectasis and can sometimes even be unhelpful or harmful [5].
Common Underlying Causes (Etiologies)
In many cases, a thorough investigation can uncover a specific cause, which allows your doctor to move from general symptom management to precision medicine [6].
- Post-Infectious: Many people develop bronchiectasis after a severe respiratory event earlier in life, such as whooping cough (pertussis), tuberculosis, or a particularly aggressive bout of pneumonia [7]. The infection causes the initial damage, and the “vicious cycle” takes over from there.
- Immunodeficiencies: Sometimes the root cause is an immune system that isn’t producing enough antibodies to fight off common bacteria [8]. Conditions like Common Variable Immunodeficiency (CVID) can be treated with immunoglobulin replacement therapy, which may prevent further lung damage [9][10].
- Primary Ciliary Dyskinesia (PCD): This is a genetic condition where the tiny hairs in your lungs (cilia) don’t beat correctly [11]. Because the “brooms” of the lung are broken, mucus and bacteria sit in the airways, leading to damage.
- Alpha-1 Antitrypsin Deficiency (AATD): This is a genetic lack of a protective protein in the blood. While often linked to emphysema, it is also a recognized cause of bronchiectasis [12][13].
Why Specialized Testing Matters
Your care team may recommend a series of tests to “rule in” or “rule out” these causes. This might include:
- Blood Work: To check your immunoglobulin levels and see how well your body responds to vaccines [9].
- Genetic Testing: Specifically for Alpha-1 or CFTR mutations [13].
- Nasal Nitric Oxide: A simple breathing test used to screen for PCD [11].
- Aspergillus Testing: To check for Allergic Bronchopulmonary Aspergillosis (ABPA), an allergic reaction to a common fungus that can cause significant airway inflammation [14].
Even if your bronchiectasis is eventually labeled “idiopathic” (meaning the cause remains unknown), the process of testing ensures that you aren’t missing out on a specific treatment that could protect your lungs for the future [15].
Next Step: Learn how to read your own reports in Understanding Your HRCT Scan and Sputum Reports.
Common questions in this guide
What is the difference between CF and non-CF bronchiectasis?
Why do I need genetic testing if I have bronchiectasis?
Can childhood infections cause bronchiectasis later in life?
What is Primary Ciliary Dyskinesia (PCD)?
How do doctors test for immune system issues related to bronchiectasis?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Have I been tested for Alpha-1 Antitrypsin deficiency, even if I don't have signs of emphysema?
- 2.Should we perform a 'nasal nitric oxide' test to screen for Primary Ciliary Dyskinesia (PCD)?
- 3.Are my immunoglobulin levels (IgG, IgA, IgM) normal, and do I need to see an immunologist to check my vaccine responses?
- 4.Is it possible that an old infection from my childhood is the reason for my bronchiectasis now?
- 5.Could my symptoms be related to Allergic Bronchopulmonary Aspergillosis (ABPA), and have I been tested for Aspergillus sensitivity?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (15)
- 1
Non-CF bronchiectasis: Orphan disease no longer.
Imam JS, Duarte AG
Respiratory medicine 2020; (166()):105940 doi:10.1016/j.rmed.2020.105940.
PMID: 32250872 - 2
[Management of adult bronchiectasis - Consensus-based Guidelines for the German Respiratory Society (DGP) e. V. (AWMF registration number 020-030)].
Ringshausen FC, Baumann I, de Roux A, et al.
Pneumologie (Stuttgart, Germany) 2024; (78(11)):833-899 doi:10.1055/a-2311-9450.
PMID: 39515342 - 3
Genetic background of pulmonary (vascular) diseases - how much is written in the codes?
Eichstaedt CA, Haas SO, Shaukat M, Grünig E
Current opinion in pulmonary medicine 2024; (30(5)):429-436 doi:10.1097/MCP.0000000000001090.
PMID: 38913028 - 4
Noncystic Fibrosis Bronchiectasis: Evaluation of an Extensive Diagnostic Protocol in Determining Pediatric Lung Disease Etiology.
Beckeringh NI, Rutjes NW, van Schuppen J, Kuijpers TW
Pediatric allergy, immunology, and pulmonology 2019; (32(4)):155-162 doi:10.1089/ped.2019.1030.
PMID: 32140286 - 5
Proteomics and Metabolomics for Cystic Fibrosis Research.
Liessi N, Pedemonte N, Armirotti A, Braccia C
International journal of molecular sciences 2020; (21(15)) doi:10.3390/ijms21155439.
PMID: 32751630 - 6
Inflammatory Phenotypes of Bronchiectasis.
Koukaki E, Papaiakovou G, Klironomou A, et al.
Journal of personalized medicine 2025; (15(10)) doi:10.3390/jpm15100499.
PMID: 41149860 - 7
Antibody deficiencies with normal IgG in adults with Non-cystic fibrosis bronchiectasis or recurrent pneumonia: Cross-sectional study.
Zea-Vera AF, Chacón MA, Parra B
Colombia medica (Cali, Colombia) 2022; (53(2)):e2014832 doi:10.25100/cm.v53i2.4832.
PMID: 36415694 - 8
Non-cystic fibrosis bronchiectasis in pediatrics: A cohort profile of patients with inborn errors of immunity at a referral center in Cali, Colombia
Murillo A, Marín D, Triviño J, et al.
Biomedica : revista del Instituto Nacional de Salud 2024; (44(Sp. 2)):131-139 doi:10.7705/biomedica.7558.
PMID: 39836842 - 9
Infections, autoimmunity and immunodeficiencies are the leading etiologies of non-cystic fibrosis bronchiectasis in adults from the southwest of Colombia.
Zea-Vera AF, Rodríguez CA, Giraldo S, et al.
Biomedica : revista del Instituto Nacional de Salud 2024; (44(Sp. 2)):80-93 doi:10.7705/biomedica.7500.
PMID: 39836848 - 10
Bronchiectasis is associated with delayed diagnosis and adverse outcomes in the New Zealand Common Variable Immunodeficiency Disorders cohort study.
Ameratunga R, Jordan A, Cavadino A, et al.
Clinical and experimental immunology 2021; (204(3)):352-360 doi:10.1111/cei.13595.
PMID: 33755987 - 11
Primary Ciliary Dyskinesia in Adult Bronchiectasis: Data from the German Bronchiectasis Registry PROGNOSIS.
Ewen R, Pink I, Sutharsan S, et al.
Chest 2024; (166(5)):938-950 doi:10.1016/j.chest.2024.05.023.
PMID: 38880279 - 12
Alpha-1 antitrypsin deficiency in bronchiectasis: Evidence for an overlooked entity beyond COPD: A retrospective observational study.
Özdemir L, Pazarli AC, Gegin S, et al.
Medicine 2026; (105(4)):e47298 doi:10.1097/MD.0000000000047298.
PMID: 41578478 - 13
Prevalence of SERPINA1 mutations in a bronchiectasis cohort: implications of extended screening for alpha-1 antitrypsin deficiency.
Sokoloski CS, Canan MGM, Leitão CA, Storrer KM
Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 2025; (51(5)):e20250181 doi:10.36416/1806-3756/e20250181.
PMID: 41370566 - 14
Aspergillus-Associated Endophenotypes in Bronchiectasis.
Jaggi TK, Ter SK, Mac Aogáin M, Chotirmall SH
Seminars in respiratory and critical care medicine 2021; (42(4)):556-566 doi:10.1055/s-0041-1730947.
PMID: 34261180 - 15
Heterogeneity in non-cystic fibrosis bronchiectasis: insights from ASPEN trial participants.
Ross MH, Jia S
ERJ open research 2024; (10(4)) doi:10.1183/23120541.00372-2024.
PMID: 39081500
This page provides general information about the underlying causes of bronchiectasis and is for educational purposes only. Always consult your pulmonologist to determine the appropriate diagnostic testing for your specific condition.
Get notified when new evidence is published on bronchiectasis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.